Skip to main content
Keymed Biosciences Inc. (HKG:2162)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
41.10
+0.75 (1.86%)
May 13, 2025, 4:08 PM HKT

Revenue by Product

Fiscal year is January - December.
Year Ending
 Dec '23 Dec '22 Dec '21
Biopharmaceutical Research and Development
391.27M
Log In
Log In
Biopharmaceutical Research and Development Growth
236.26%
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Year Ending
 Dec '23 Dec '22 Dec '21
Overseas
390.28M
Log In
Log In
China
997.81K
Log In
Log In
China Growth
-99.14%
Log In
Log In